,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1164746,55245,Comparative Toxicogenomics Database (CTD),Mifepristone,D015735,Mifepristone,https://ctdbase.org/detail.go?type=chem&acc=D015735,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270,SERPINE2,10116,Rattus norvegicus (Norway rat),Mifepristone results in decreased expression of SERPINE2 mRNA,,,PMID:25972201,https://www.ncbi.nlm.nih.gov/pubmed/25972201,25972201.0,,
1,1164747,55245,Comparative Toxicogenomics Database (CTD),Mifepristone,D015735,Mifepristone,https://ctdbase.org/detail.go?type=chem&acc=D015735,5176,SERPINF1,https://ctdbase.org/detail.go?type=gene&acc=5176,,,5176,SERPINF1,9606,Homo sapiens (human),Mifepristone results in decreased expression of SERPINF1 mRNA,,,PMID:17584828,https://www.ncbi.nlm.nih.gov/pubmed/17584828,17584828.0,,
2,1164743,124437,Therapeutic Target Database (TTD),((4-Phenyl-1-(4-(2-quinolinylmethoxy)phenyl)butyl)thio)acetic acid,D02RZL,AZD4769,https://idrblab.net/ttd/data/drug/details/D02RZL,T59328,Epidermal growth factor receptor (EGFR),https://idrblab.net/ttd/data/target/details/T59328,P00533,Epidermal growth factor receptor,1956,EGFR,9606,Homo sapiens (human),Inhibitor,,,,,,,
3,1164744,124437,Therapeutic Target Database (TTD),((4-Phenyl-1-(4-(2-quinolinylmethoxy)phenyl)butyl)thio)acetic acid,D02RZL,AZD4769,https://idrblab.net/ttd/data/drug/details/D02RZL,T46642,Arachidonate 5-lipoxygenase activating protein (FLAP),https://idrblab.net/ttd/data/target/details/T46642,P20292,Arachidonate 5-lipoxygenase-activating protein,241,ALOX5AP,9606,Homo sapiens (human),Inhibitor,,,,,,,
4,1164745,124449,Comparative Toxicogenomics Database (CTD),4-Hydroxymidazolam,C042940,4-hydroxymidazolam,https://ctdbase.org/detail.go?type=chem&acc=C042940,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576,CYP3A4,9606,Homo sapiens (human),[CYP3A4 protein results in increased oxidation of midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam|galangin inhibits the reaction [[CYP3A4 protein results in increased oxidation of midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]|flavanone inhibits the reaction [[CYP3A4 protein results in increased oxidation of midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]|acacetin inhibits the reaction [[CYP3A4 protein results in increased oxidation of midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]|apigenin inhibits the reaction [[CYP3A4 protein results in increased oxidation of midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam]|flavone inhibits the reaction [[CYP3A4 protein results in increased oxidation of midazolam] which results in increased chemical synthesis of 4-hydroxymidazolam],,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930.0,,
